Assemble and accelerate the business and front-line impact of health-tech solutions that fit the following criteria:
1. Solutions that improve the experience of those with Dementia and/or Frailty.
For vulnerable residents at risk of presenting at hospitals through social isolation, frailty and dementia.
2. Solutions allowing primary care and outpatient services to be delivered in or near the home for patients.
For patients with a long-term condition that requires regular attendance at outpatient clinics or in a primary care setting.
3. Innovations to allow Digital Nudges to improve Prevention and Public Health
Helping people at risk of developing conditions whose outcomes can be improved through lifestyle change.
Solutions were evaluated against the potential Life Impact for each resident or patient type listed above, and the ability to see evidential improvement in:
i) the patient holistic care experience
ii) the capacity and management of primary, community and secondary care.
At Novartis, we are committed to reimagining medicine through digital and data. As our population grows and ages, we need more innovative solutions to society’s complex and chronic health needs. Through our involvement with The Greater Manchester Future of Health, Novartis aimed to empower and accelerate emerging health-tech start-ups to develop and implement their innovative solutions. We were excited to assemble such an interesting and innovative group of start-ups and entrepreneurs and enjoyed collaborating with them during the programme.
Karen Fox, Head of Strategic Partnerships, Novartis